Status:

COMPLETED

Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients

Lead Sponsor:

Seoul National University Hospital

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Conditions:

Aplastic Anemia

Myelodysplastic Syndromes

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

To investigate the efficacy of posaconazole as prophylaxis antifungal agent in aplastic anemia / hypoplastic myelodysplastic syndrome (AA/hMDS) patients undergoing antithymocyte globulin (ATG) treatme...

Detailed Description

With compromised bone marrow function, patients with aplastic anemia (AA) and/and hypoplastic myelodysplastic syndrome (hMDS) are at an increased risk of invasive fungal infection. Moreover, the use o...

Eligibility Criteria

Inclusion

  • willing and able to provide written informed consent for voluntary participation in the trial
  • adult patients (≥18 years, \<75 years old)
  • no QTc prolongation on initial ECG
  • Adequate organ function for treatment as follows:
  • A. Absolute neutrophil count \> 1.5 x 109/L B. Platelets \>100 x 109/L C. Serum creatinine ≤ 2.0 x ULN (upper limit of normal) D. Serum bilirubin ≤ 1.5 x ULN E. AST and ALT ≤ 2.0 x ULN

Exclusion

  • those suspected of fungal infection within 30 days of ATG treatment
  • those allergic to -triazoles
  • those with history of malignancies within 5 years and/or concomitant malignancy other than AA/hMDS
  • those with history of chemotherapy, radiotherapy and/or other immunosuppressants
  • female patients who are pregnant, breast-feeding or male or female patients of reproductive potential who are not employing an effective method of birth control
  • active HBV, HCV patients
  • HIV positive patients
  • those with history of receiving organ transplantation

Key Trial Info

Start Date :

April 20 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 15 2023

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03318159

Start Date

April 20 2018

End Date

July 15 2023

Last Update

December 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea